cardiovascular health

Xylitol linked to 57% higher heart attack risk, study finds

A widely used sugar substitute found in chewing gum, toothpaste, and low-calorie snacks may carry hidden cardiovascular risks, according to new research presented at the European Society of Cardiology Congress 2026 in Munich. The study found that people with the…

Novo Nordisk launches Wegovy pill in Germany, its first EU market

As Novo Nordisk expands the global footprint of its blockbuster weight-loss drug Wegovy, the cardiovascular benefits first demonstrated in the SELECT trial remain central to the medication's growing dominance and widening insurance coverage.

Study links xylitol to higher heart attack, stroke risk

A common sugar substitute found in sugar-free chewing gum, mints, toothpaste, and low-calorie foods has been linked to a higher risk of heart attack, stroke, and death in a large-scale study presented at the European Society of Cardiology (ESC) Congress…

Wegovy is only obesity drug linked to reduced death risk, BMJ analysis finds

A comprehensive analysis published in The BMJ on July 8 found that subcutaneous semaglutide — marketed as Wegovy — is the only obesity drug associated with reduced risks of death, heart attack, and heart failure, reinforcing Novo Nordisk's position in…